1. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data

   • Gianluigi Tanda
   • Steven R. Goldberg

   Review 24 June 2003 Pages: 115 - 134

   

2. Self-administration of Δ⁹-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

   • Zuzana Justinova
   • Gianluigi Tanda
   • Steven R. Goldberg

   Original Investigation 24 June 2003 Pages: 135 - 140

   

3. Adolescent-onset nicotine self-administration modeled in female rats

   • Edward D. Levin
   • Amir H. Rezvani
   • H. Scott Swartzwelder

   Original Investigation 23 May 2003 Pages: 141 - 149

   

4. Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential

   • John N. Bain
   • Mark A. Prendergast
   • Jerry J. Buccafusco

   Original Investigation 27 May 2003 Pages: 150 - 160

   

5. Locomotor and discriminative-stimulus effects of cocaine in dopamine D₅ receptor knockout mice

   • Elizabeth E. Elliot
   • David R. Sibley
   • Jonathan L. Katz

   Original Investigation 27 May 2003 Pages: 161 - 168

   

6. Long-lasting effects of chronic stress on DOI-induced hyperthermia in male rats

   • Leslie Matuszewich
   • Bryan K. Yamamoto

   Original Investigation 27 May 2003 Pages: 169 - 175

   

7. On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization

   • Louk J. M. J. Vanderschuren
   • Patricia Beemster
   • Anton N. M. Schoffelmeer

   Original Investigation 27 May 2003 Pages: 176 - 185

   

8. Hypericum perforatum attenuates nicotine withdrawal signs in mice

   • Maria A. Catania
   • Fabio Firenzuoli
   • Gioacchino Calapai

   Original Investigation 29 April 2003 Pages: 186 - 189

   

9. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice

   • Christopher L. Kliethermes
   • Deborah A. Finn
   • John C. Crabbe

   Original Investigation 29 May 2003 Pages: 190 - 197

   

10. Expectations and placebo responses to caffeine-associated stimuli

    • Magne Arve Flaten
    • Ole Aasli
    • Terry D. Blumenthal

    Original Investigation 21 May 2003 Pages: 198 - 204

    

11. Varying and "atypical" indications for atypical antipsychotics

    • Corrado Barbui
    • Michele Tansella
    • Silvio Garattini

    Letter to the Editors 22 May 2003 Pages: 205 - 206

12. Second-generation antipsychotics: discrepancies between licensed indications, evidence base and actual use

    • W. Wolfgang Fleischhacker
    • the European Group for Research in Schizophrenia

    Letter to the Editors 22 May 2003 Pages: 207 - 210

13. Lorazepam should no longer be used as a prototypical benzodiazepine

    • S. Pompéia
    • O. F. A. Bueno
    • S. Tufik

    Letter to the Editors 28 May 2003 Pages: 211 - 212